Company Comparison
BioRegen Labs vs BioDefense Pro
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | BioRegen Labs | BioDefense Pro |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Basel | Cambridge |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | Series C | Seed |
| Total Funding | $150M | $11M |
| Valuation | — | — |
What They Build
BioRegen Labs
A Basel-based regenerative medicine company with $150M in Series C funding, developing advanced regenerative therapies and technologies.
BioDefense Pro
A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.
Sector Overlap
Both BioRegen Labs and BioDefense Pro operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
14-day free trial. No credit card required.